Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
AssigneeGuilford Pharmaceuticals Inc.
InventorsBarbara S. Slusher, Rena Lapidus
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a method of inhibiting angiogenesis comprising administering a N-Acetylated α-Linked Acidic Dipeptidase (NAALADase) inhibitor to a patient in need thereof, and a pharmaceutical composition comprising an anti-angiogenic effective amount of a NAALADase inhibitor and a pharmaceutically acceptable carrier.
Claims46
A method of inhibiting angiogenesis in non-cancerous tissue comprising administering an anti-angiogenic amount of a NAALADase inhibitor to a patient in need of angiogenesis inhibition suffering from a disease, disorder, or condition other than cancer, wherein said tissue is other than prostate tissue.
Dependencies are inferred from the claim text.